Related Experiment Video
Updated: Jul 1, 2025

Chronic Salmonella Infection Induced Intestinal Fibrosis
Published on: September 22, 2019
Inflammatory bowel disease activity threatens ankylosing spondylitis: implications from Mendelian randomization
Yimei Ding1, Jiaxu Chen1, Rouxin Li1
1Department of Rheumatology and Immunology, Yueyang Hospital of Integrated Traditional Chinese and Western Medicine, Shanghai University of Traditional Chinese Medicine, Shanghai, China.
Inflammatory bowel disease (IBD) significantly increases the risk of developing ankylosing spondylitis (AS). Active IBD further exacerbates this risk, highlighting the link between gut and joint inflammation.
Area of Science:
- Genetics and immunology
- Gastroenterology and rheumatology
Background:
- Inflammatory bowel disease (IBD) and ankylosing spondylitis (AS) share inflammatory characteristics affecting the gut and joints.
- Epidemiological data suggest an increased incidence of AS in IBD patients, but causality and the role of IBD activity remain unclear.
Purpose of the Study:
- To investigate if IBD is a risk factor for AS development using Mendelian randomization.
- To explore the impact of IBD disease activity on the risk and progression of AS.
Main Methods:
- Two-sample Mendelian randomization (MR) analyses were performed across multiple datasets.
- Transcriptome analysis, including gene set enrichment and correlation analyses, was used to identify risk genes and pathways.
Main Results:
- MR analyses consistently showed that IBD significantly elevates the risk of AS.
- Higher risk scores and distinct molecular profiles (transcription factors, pathways, immune cells) were observed in active IBD patients.
- Seven immune cell types showed significant correlations with identified AS risk genes.
Conclusions:
- IBD is a significant risk factor for AS development.
- IBD activity demonstrably impacts the progression of AS, supported by combined MR and transcriptome data.
More Related Videos
Related Concept Videos
Genome-wide Association Studies-GWAS
GWAS does not require the identification of the target gene involved in...
Inflammatory Bowel Disease II: Crohn's Disease
Inflammatory bowel disease, commonly known as IBD, refers to a collection of disorders that lead to persistent inflammation of the gastrointestinal tract. The two types of IBD are ulcerative colitis, which impacts the colon, and Crohn's disease, which can involve any part of the gastrointestinal segment.
Crohn's disease
Crohn's disease is a chronic, systemic inflammatory bowel disease (IBD) that predominantly affects the gastrointestinal tract. It is marked by...
Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
The JAK-STAT Signaling Pathway
Inflammatory Bowel Disease IV: Pharmacological Management
Pharmacologic...
Inflammatory Bowel Disease I: Ulcerative Colitis
Inflammatory bowel disease, or IBD, encompasses a group of disorders characterized by chronic inflammation or ulceration of the gastrointestinal tract.
Risk Factors
The exact cause of IBD remains unclear, although it is believed to be due to a mix of genetic, environmental, microbial, and immune factors. Genetic factors are significant in determining susceptibility to IBD, with family history being a critical risk factor. Individuals with a first-degree relative who has IBD are at...

